Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

293
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
293
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

2.1K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.1K
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

610
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
610
Secondary Healthcare System01:11

Secondary Healthcare System

1.4K
Secondary healthcare is offered by a specialist, generally in hospitals or clinics for patients referred by primary healthcare providers. It occurs when a person has an illness or injury that requires specific medical care. Secondary care is often referred to as acute care. Secondary care can range from uncomplicated care to repair a minor laceration or treat a strep throat infection to more complicated emergent care, such as treating a head injury sustained in an automobile accident. Whatever...
1.4K
Errors occurring during blood pressure monitoring01:25

Errors occurring during blood pressure monitoring

661
Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...
661
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

142
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
142

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

"Ticagrelor or Prasugrel, Doctor?": A Yet Unresolved Conundrum Following Percutaneous Coronary Intervention for Acute Coronary Syndrome.

The Canadian journal of cardiology·2026
Same author

Automated assessment of right ventricular systolic function from coronary angiograms with video-based artificial intelligence algorithms: development, validation, comparison against humans, and prospective deployment.

European heart journal. Digital health·2026
Same author

A Novel Approach for Catheter Knots and Kinks Using a Grasping Device.

JACC. Case reports·2026
Same author

Surgical Risk and Revascularization-An Update.

Journal of the Society for Cardiovascular Angiography & Interventions·2026
Same author

Low-Dose Aspirin for Cardiovascular Prevention in Giant Cell Arteritis-Time to Reconsider?

JAMA network open·2026
Same author

Practice Patterns in Antiplatelet Management of Patients With Acute Coronary Syndromes Treated Medically Without Revascularisation: A Multicentre Survey.

The Canadian journal of cardiology·2026

Related Experiment Video

Updated: Jun 17, 2025

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.6K

Care Gaps and System Issues With Delivering Cardiovascular Risk Reduction and Lipid-Lowering Therapy in Secondary

Guillaume Marquis-Gravel1, Sacha Bhatia2, Vivien Brown3

  • 1Montreal Heart Institute, Université de Montréal, Montréal, Québec, Canada.

The Canadian Journal of Cardiology
|August 7, 2024
PubMed
Summary

This study highlights gaps in lipid management for atherosclerotic cardiovascular disease (ASCVD) patients after procedures like percutaneous coronary intervention (PCI). Targeted education improves lipid-lowering therapy adherence and outcomes in high-risk populations.

More Related Videos

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

14.6K
Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
05:41

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control

Published on: December 16, 2022

3.4K

Related Experiment Videos

Last Updated: Jun 17, 2025

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.6K
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

14.6K
Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
05:41

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control

Published on: December 16, 2022

3.4K

Area of Science:

  • Cardiology
  • Clinical Practice
  • Public Health

Background:

  • Significant care gaps exist in lipid-lowering therapy for atherosclerotic cardiovascular disease (ASCVD).
  • Challenges in lipid management persist, particularly after percutaneous coronary intervention (PCI) and acute coronary syndrome (ACS).
  • Discrepancies noted between recommended guidelines and actual clinical implementation of lipid-lowering treatments.

Purpose of the Study:

  • To examine care gaps in lipid-lowering therapy for ASCVD patients.
  • To identify challenges in lipid management post-PCI and ACS.
  • To evaluate the effectiveness of interventions in improving lipid management outcomes.

Main Methods:

  • Review of studies focusing on lipid testing and treatment adequacy post-PCI and ACS.
  • Analysis of knowledge and practice gaps among primary care practitioners regarding lipid guidelines.
  • Evaluation of initiatives like GOAL Canada and ACS Reflective III Pilot.

Main Results:

  • Identified gaps in lipid testing and treatment adequacy following PCI and ACS.
  • Demonstrated improvements in nonstatin therapy uptake and LDL cholesterol target achievement through educational interventions.
  • Highlighted persistent systemic challenges in drug approval and reimbursement affecting newer agent accessibility.

Conclusions:

  • Targeted educational interventions can improve lipid management outcomes in high-risk ASCVD populations.
  • These interventions show potential to positively influence clinical practice.
  • Addressing systemic barriers is crucial for enhancing access to advanced lipid-lowering therapies.